In this regard, Makinoshima H et al., published data showing that epidermal growth factor receptor (EGFR) signaling actually regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma [11]. The gene discussed is EGFR; the disease is lung adenocarcinoma.